Clinical Trials

Ovarian Cancer

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 3 of 3 Clinical Trials Related to Ovarian Cancer

Clinical Research Trial

Amgen 757 Lung Cancer

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306)

Doctor(s) Running This Study
Suresh G. Nair, MD
Nicholas E. Lamparella, DO
M. Bijoy Thomas, MD
Jeffrey T. Brodsky, MD
Brian J. Patson, MD
Maged F. Khalil, MD
Bradley W. Lash, MD
Jeanette M. Blauth, MD
Lori A. Alfonse, DO
Simi Masand Rai, MD
Don J. Park, MD, PHD
Muhammad A. Rizvi, MD
Hasan H. Danish, MD
Heiwon Chung Whang, MD
Eliot L. Friedman, MD
Tara Morrison, MD
Paul Palyca, MD
Alyson F. McIntosh, MD, MPHIL
Aaron U. Blackham, MD
Clinical Research Trial

NRG-GY005

A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women with Recurrent Platinum-Resistant or -Refractory

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

NRG GY-014

A Phase II Study of Tazemetostat (EPZ-6438) (IND # 138671) in Recurrent or Persistent Endometrioid or Clear Cell Carcinoma of the Ovary, and Recurrent or Persistent Endometrioid Endometrial Adenocarcinoma

Doctor(s) Running This Study
Maged F. Khalil, MD